# Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control

> **NCT04108351** · NA · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **OTHER:** Road-tracking test
- **OTHER:** Car-following test
- **OTHER:** Harsh-braking test

## Key facts

- **NCT ID:** NCT04108351
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-07
- **Primary completion:** 2020-02-11
- **Final completion:** 2020-02-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04108351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04108351, "Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04108351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*